Nanomedicine : Impact Factor & More
eISSN: 1748-6963pISSN: 1743-5889
Share this on:
Key Metrics
CiteScore 
8.3
Impact Factor
5 - 10
SNIP
0.83
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Nanomedicine
Nanomedicine Journal Specifications
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Nanomedicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Nanomedicine
Resveratrol-loaded liposomes regulate mitochondrial oxidative stress through the HIGD1A/NF-κB/SOD2 signaling pathway to improve chemotherapy-induced ovarian injury.
- 13 May 2026
- Nanomedicine (London, England)
Hydrogels for the treatment of spinal cord injury: progress and promise.
- 12 May 2026
- Nanomedicine (London, England)
Pulmonary delivery of gene-loaded lipid nanoparticles for targeting TGF-β signaling in idiopathic pulmonary fibrosis.
- 11 May 2026
- Nanomedicine (London, England)
Microglia encapsulation in nanozyme-loaded hydrogels: response to oxidative stress and inflammation.
- 8 May 2026
- Nanomedicine (London, England)
Nanofiber based transformative approaches for tendon regenerative engineering: past, present and future.
- 8 May 2026
- Nanomedicine (London, England)
Nanoparticle-based approaches to tackling urinary tract biofilms.
- 7 May 2026
- Nanomedicine (London, England)
Resveratrol-loaded liposomes regulate mitochondrial oxidative stress through the HIGD1A/NF-κB/SOD2 signaling pathway to improve chemotherapy-induced ovarian injury.
- 13 May 2026
- Nanomedicine (London, England)
Hydrogels for the treatment of spinal cord injury: progress and promise.
- 12 May 2026
- Nanomedicine (London, England)
Pulmonary delivery of gene-loaded lipid nanoparticles for targeting TGF-β signaling in idiopathic pulmonary fibrosis.
- 11 May 2026
- Nanomedicine (London, England)
Microglia encapsulation in nanozyme-loaded hydrogels: response to oxidative stress and inflammation.
- 8 May 2026
- Nanomedicine (London, England)
Nanofiber based transformative approaches for tendon regenerative engineering: past, present and future.
- 8 May 2026
- Nanomedicine (London, England)
Nanoparticle-based approaches to tackling urinary tract biofilms.
- 7 May 2026
- Nanomedicine (London, England)
FAQs on Nanomedicine
How long has Nanomedicine been actively publishing? 
What is the publishing frequency of Nanomedicine?
How many articles did Nanomedicine publish last year?
What is the eISSN & pISSN for Nanomedicine?
What is Citescore for Nanomedicine?
What is SNIP score for Nanomedicine?
Who is the publisher of Nanomedicine?
